Filing Details
- Accession Number:
- 0001127602-15-022610
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-08 20:00:13
- Reporting Period:
- 2015-07-07
- Filing Date:
- 2015-07-08
- Accepted Time:
- 2015-07-08 20:00:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1205236 | R David Walt | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-07-07 | 600 | $218.51 | 703,737 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-07-07 | 3,900 | $219.68 | 699,837 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-07-07 | 4,100 | $220.58 | 695,737 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-07-07 | 1,400 | $221.39 | 694,337 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-07-07 | 200 | $218.79 | 52,760 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2015-07-07 | 1,000 | $219.89 | 51,760 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2015-07-07 | 700 | $220.76 | 51,060 | No | 4 | S | Indirect | By Spouse |
Common Stock | Disposition | 2015-07-07 | 100 | $221.49 | 50,960 | No | 4 | S | Indirect | By Spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 600 shares sold ranging from $218.15 to $218.76 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 3,900 shares sold ranging from $219.21 to $220.205 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 4,100 shares sold ranging from $220.21 to $221.20 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,400 shares sold ranging from $221.24 to $221.665 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 200 shares sold ranging from $218.32 to $219.25 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,000 shares sold ranging from $219.33 to $220.32 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 700 shares sold ranging from $220.35 to $221.28 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.